𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of didemnin B in advanced colorectal cancer

✍ Scribed by Dennie V. Jones; Jaffer A. Ajani; Roxann Blackburn; Karen Daugherty; Bernard Levin; Yehuda Z. Patt; James L. Abbruzzese

Publisher
Springer US
Year
1992
Tongue
English
Weight
222 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of menogaril in advanced
Phase II trial of menogaril in advanced colorectal cancer
✍ Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig; πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 262 KB

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach

Phase I-II study of ftorafur and methyl-
Phase I-II study of ftorafur and methyl-ccnu in advanced colorectal cancer
✍ Robert J. Belt; Ronald Stephens πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 316 KB πŸ‘ 2 views

The combination of Ftorafur (NSC-148958) and methyl-CCNU (NSC-95441) was evaluated in 36 patients with advanced colorectal cancer. The principle toxicities encountered were myelosuppression, gastrointestinal, and neurological. There were no complete responses and only 5/34 (14.7%) patients achieved

A phase II study of sequential methotrex
A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer
✍ L. Panasci; J. Ford; R. Margolese πŸ“‚ Article πŸ“… 1985 πŸ› Springer 🌐 English βš– 242 KB

Twenty-nine patients with advanced colorectal cancer were treated with methotrexate (MTX) 200 mg/m2 followed 1 h later by fluorouracil (FU) (1000 mg/m2) and 24 h later by oral leucovorin 20 mg every 6 h for six doses. The cycle was repeated every 2 weeks. Among the 25 evaluable patients there were 2